IR-Med Inc. – OTC:IRME

IR-Med stock price today

$0.018
-0.48
-96.44%
Financial Health
0
1
2
3
4
5
6
7
8
9

IR-Med stock price monthly change

-5.66%
month

IR-Med stock price quarterly change

-5.66%
quarter

IR-Med stock price yearly change

-56.52%
year

IR-Med key metrics

Market Cap
28.51M
Enterprise value
23.35M
P/E
-5.21
EV/Sales
N/A
EV/EBITDA
-9.08
Price/Sales
N/A
Price/Book
10.15
PEG ratio
-0.05
EPS
-0.06
Revenue
N/A
EBITDA
-4.19M
Income
-4.21M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

IR-Med stock price history

IR-Med stock forecast

IR-Med financial statements

IR-Med Inc. (OTC:IRME): Profit margin
Jun 2023 0 -1.10M
Sep 2023 0 -1.17M
Dec 2023 34K -1.27M -3738.24%
Mar 2024 0 -657K
IR-Med Inc. (OTC:IRME): Analyst Estimates
2025 9.25M 2.08M 22.51%
2026 30.9M 11.79M 38.18%
  • Analysts Price target

  • Financials & Ratios estimates

IR-Med Inc. (OTC:IRME): Earnings per share (EPS)
2024-04-01 -0.02 -0.02
IR-Med Inc. (OTC:IRME): Debt to assets
Jun 2023 2622000 614K 23.42%
Sep 2023 1773000 561K 31.64%
Dec 2023 999000 634K 63.46%
Mar 2024 579000 665K 114.85%
IR-Med Inc. (OTC:IRME): Cash Flow
Jun 2023 -767K 0 1M
Sep 2023 -811K -1K 0
Dec 2023 -754K -1K 754.24K
Mar 2024 -358K 0 0

IR-Med alternative data

IR-Med Inc. (OTC:IRME): Employee count
Aug 2023 7
Sep 2023 7
Oct 2023 7
Nov 2023 7
Dec 2023 7
Jan 2024 7
Feb 2024 7
Apr 2024 7
May 2024 6
Jun 2024 6
Jul 2024 6

IR-Med other data

Tuesday, 10 September 2024
globenewswire.com
Wednesday, 28 August 2024
globenewswire.com
Wednesday, 21 August 2024
globenewswire.com
Monday, 15 July 2024
globenewswire.com
Wednesday, 22 May 2024
globenewswire.com
Friday, 5 April 2024
globenewswire.com
Tuesday, 20 February 2024
globenewswire.com
Tuesday, 13 February 2024
GlobeNewsWire
Tuesday, 14 March 2023
GlobeNewsWire
  • What's the price of IR-Med stock today?

    One share of IR-Med stock can currently be purchased for approximately $0.02.

  • When is IR-Med's next earnings date?

    Unfortunately, IR-Med's (IRME) next earnings date is currently unknown.

  • Does IR-Med pay dividends?

    No, IR-Med does not pay dividends.

  • How much money does IR-Med make?

    IR-Med has a market capitalization of 28.51M. IR-Med made a loss 4.91M US dollars in net income (profit) last year or -$0.02 on an earnings per share basis.

  • What is IR-Med's stock symbol?

    IR-Med Inc. is traded on the OTC under the ticker symbol "IRME".

  • What is IR-Med's primary industry?

    Company operates in the Healthcare sector and Medical Devices industry.

  • How do i buy shares of IR-Med?

    Shares of IR-Med can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does IR-Med have?

    As Jul 2024, IR-Med employs 6 workers, which is 14% less then previous quarter.

  • What is IR-Med's official website?

    The official website for IR-Med is ir-medical.com.

  • How can i contact IR-Med?

    IR-Med can be reached via phone at +972 4 655 5054.

IR-Med company profile:

IR-Med Inc.

ir-medical.com
Exchange:

OTC

Full time employees:

8

Industry:

Medical Devices

Sector:

Healthcare

IR-Med Inc., a development stage medical device company, focuses on the development of infra-red light spectroscopy combined with artificial intelligence technology platform to address diagnostic or medical needs. It is developing PressureSafe, a handheld optical monitoring device to support early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear infection (Otitis Media), a common malady in children. The company is headquartered in Rosh Pina, Israel.

ZHR Industrial Zone
Rosh Pinna,

CIK: 0001839133
:
: